EVASENSE

WIPO WIPO 2010

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark EVASENSE was filed as Word mark on 06/19/2010 at the World Intellectual Property Organization.

Trademark Details Last update: June 29, 2021

Trademark form Word mark
File reference 1050835
Countries European Community Japan United States of America (USA)
Base trademark GB No. 2546170, April 30, 2010
Application date June 19, 2010
Expiration date June 19, 2020

Trademark owner

The Broadgate Tower, 3rd Floor,
20 Primrose Street
GB

Trademark representatives

The Grange, Hinderclay Suffolk IP22 1HX GB

goods and services

05 Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke

Trademark history

Date Document number Area Entry
June 26, 2021 2021/25 Gaz Deletion
June 7, 2018 2018/35 Gaz US RAW: Total Invalidation
August 17, 2011 2011/33 Gaz EM Rejection
April 27, 2011 2011/20 Gaz US Rejection
January 13, 2011 2011/2 Gaz JP Rejection
June 19, 2010 2010/39 Gaz GB Registration

ID: 141050835